http://www.news.com.au/technology/a...k/news-story/a10e9f49bd69c10bc21ae31da2e5296c ...suggests there may be more demand here at home than we recognise...
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%